Beautiful Virgin Islands

Tuesday, Jun 03, 2025

Coronavirus: as governments feud, researchers, scientists and tech firms fill collaborative void in search for cure

Coronavirus: as governments feud, researchers, scientists and tech firms fill collaborative void in search for cure

Joint efforts of health care industry, pharmaceutical companies and tech firms are a stark contrast to the Washington-Beijing divisiveness. As many as 332 Covid-19 clinical trials have been launched from China, South Korea, Europe and North America, according to the medical journal The Lancet

Despite the spread of the coronavirus that has infected 1.5 million people and devastated economies around the world, the United States and China have proven unable to work together at the government level to battle the human crisis. But researchers and scientists from both countries – as well as others – are locking arms to advance vaccines and treatments for Covid-19 from the ground up.

In March, US tech giant Intel and Hong Kong-headquartered Lenovo teamed up to offer supercomputing capacity to support scientists at Shenzhen, China-based BGI Genomics to analyse the virus’ genome. The tech boost will speed up the sequencing, critical in developing vaccines and treatments, to five and a half hours from the previous 150 hours.

As many as 332 Covid-19 clinical trials have been launched from China, South Korea, Europe and North America, with 188 looking for patient recruitment globally, according to the medical journal The Lancet.

“Global collaboration is now more important than ever, as scientists across the world race against time to develop a drug or vaccine that can treat this virus and save lives,” said Dr Yongwei Zhang, a BGI vice-president who oversees the Americas business. “Diseases know no borders.”



The virus has been confirmed in at least 184 countries worldwide and claimed more than 87,000 lives in a matter of months.

The efforts of hospitals, clinics, research centers, pharmaceutical companies and tech firms to find desperately needed remedies mark a stark contrast to the divisiveness that has characterised the US-China relationship for the past few years.

Just weeks after Washington and Beijing signed a phase one deal in a trade war that had lasted nearly two years, the US found itself in virtual physical and economic lockdown.

The White House’s approach remained more nationalistic than global. Unlike previous administrations that led the world and fostered multilateral collaborations during crises, President Donald Trump persists with his nationalistic theme.

Trump has said that the US has the best doctors and scientists and it can deal with the problem right at home.

“The pandemic and the response to it have revealed and reinforced the fundamental characteristics of geopolitics today,” Richard Haass wrote in Foreign Affairs.

“Waning American leadership, faltering global cooperation, great-power discord: all of these characterised the international environment before the appearance of Covid-19, and the pandemic has brought them into sharper-than-ever relief. They are likely to be even more prominent features of the world that follows,” he said.


As the virus spread, the blame game began. A Chinese Foreign Ministry spokesman had claimed the origin of the virus could have been US military personnel who travelled to Wuhan, China, last fall. Trump responded by calling the contagion the “Chinese virus”.

The scientific community pushed back. In late February, a group of 27 public health scientists said in a statement published in The Lancet: “we stand together to strongly condemn conspiracy theories suggesting that Covid-19 does not have a natural origin.”

“The rapid, open and transparent sharing of data on this outbreak is now being threatened by rumours and misinformation around its origins,” they wrote.

“We have watched as the scientists, public health professionals and medical professionals of China, in particular, have worked diligently and effectively to rapidly identify the pathogen behind this outbreak, put in place significant measures to reduce its impact and share their results transparently with the global health community.”



In early January, scientists in China sequenced the virus’ genome and made it public on an open-access site, the Nucleotide Database at the National Center for Biotechnology Information.

The publication was a critical step that allowed scientists worldwide to develop diagnosis protocols and to start developing potential treatments.

One promising vaccine candidate developed by Johnson & Johnson traced its roots back to that research. The company said in its press release that it “began efforts as soon as the novel coronavirus sequence became available”.

Massachusetts General Hospital in Boston, which is affiliated with Harvard University, has teamed up with Xijing Hospital in Xi’an, China, to test inhalable nitric oxide, the component used in Viagra, as a potential coronavirus treatment for patients with mild to moderate symptoms.

In March, the Bill & Melinda Gates Foundation joined Mastercard and Wellcom, a British-based foundation supporting medical research, to establish the Covid-19 Therapeutics Accelerator. The programme aims to speed the development of and access to therapies for the disease, committing up to US$125 million in funding.

The initiative is looking to identify about 50 to 100 drugs already approved by the US Food and Drug Administration, then narrow the list to a few that can be scaled up.

More than 30 leading publishers, including the Chinese Centre for Disease Control and Prevention and the Chinese Journal of Lung Cancer, have committed to making all of their Covid-19 and coronavirus-related publications accessible and reusable.

In the US, the local business community reached out to Chinese companies independently to address the shortage of testing. A few days ago, BGI shipped 50,000 testing kits to the Kansas City metropolitan area in a partnership with local business leaders and the University of Kansas Health System.

Nathaniel Hagedorn, CEO of NorthPoint Development in Riverside, Missouri, started searching for companies that provided test kits to China and South Korea when four employees showed symptoms of infection but couldn’t get tested.

Five local business executives purchased the test kits, which have been used in more than a million diagnoses.

“Businesses can make a big difference, and our country needs effective leadership at this time,” Hagedorn said.

Said BGI’s Zhang: “The harsh reality of Covid-19 is that we are all connected. The consequences [of not working together], unfortunately, will be human lives lost.”

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Dutch government falls as far-right leader Wilders quits coalition
Harvard Urges US to Unfreeze Funds for Public Health Research
Businessman Mauled by Lion at Luxury Namibian Lodge
Researchers Consider New Destinations Beyond the U.S.
53-Year-Old Doctor Claims Biological Age of 23
Trump Struggles to Secure Trade Deals With China and Europe
Russia to Return 6,000 Corpses Under Ukraine Prisoner Swap Deal
Microsoft Lays Off Hundreds More Amid Restructuring
Harvey Weinstein’s Publicist Embraces Notoriety
Macron and Meloni Seek Unity Despite Tensions
Trump Administration Accused of Obstructing Deportation Cases
Newark Mayor Sues Over Arrest at Immigration Facility
Center-Left Candidate Projected to Win South Korean Presidency
Trump’s Tariffs Predicted to Stall Global Economic Growth
South Korea’s President-Elect Expected to Take Softer Line on Trump and North Korea
Trump’s China Strategy Remains a Geopolitical Puzzle
Ukraine Executes Long-Range Drone Strikes on Russian Airbases
Conservative Karol Nawrocki wins Poland’s presidential election
Study Identifies Potential Radicalization Risk Among Over One Million Muslims in Germany
Good news: Annalena Baerbock Elected President of the UN General Assembly
Apple Appeals EU Law Over User Data Sharing Requirements
South Africa: "First Black Bank" Collapses after Being Looted by Owners
Poland will now withdraw from the EU migration pact after pro-Trump nationalist wins Election
"That's Disgusting, Don’t Say It Again": The Trump Joke That Made the President Boil
Trump Cancels NASA Nominee Over Democratic Donations
Paris Saint-Germain's Greatest Triumph Is Football’s Lowest Point
OnlyFans for Sale: From Lockdown Lifeline to Eight-Billion-Dollar Empire
Mayor’s Security Officer Implicated | Shocking New Details Emerge in NYC Kidnapping Case
Hegseth Warns of Potential Chinese Military Action Against Taiwan
OPEC+ Agrees to Increase Oil Output for Third Consecutive Month
Jamie Dimon Warns U.S. Bond Market Faces Pressure from Rising Debt
Turkey Detains Istanbul Officials Amid Anti-Corruption Crackdown
Taylor Swift Gains Ownership of Her First Six Albums
Bangkok Ranked World's Top City for Remote Work in 2025
Satirical Sketch Sparks Political Spouse Feud in South Korea
Indonesia Quarry Collapse Leaves Multiple Dead and Missing
South Korean Election Video Pulled Amid Misogyny Outcry
Asian Economies Shift Away from US Dollar Amid Trade Tensions
Netflix Investigates Allegations of On-Set Mistreatment in K-Drama Production
US Defence Chief Reaffirms Strong Ties with Singapore Amid Regional Tensions
Vietnam Faces Strategic Dilemma Over China's Mekong River Projects
Malaysia's First AI Preacher Sparks Debate on Islamic Principles
White House Press Secretary Criticizes Harvard Funding, Advocates for Vocational Training
France to Implement Nationwide Smoking Ban in Outdoor Spaces Frequented by Children
Meta and Anduril Collaborate on AI-Driven Military Augmented Reality Systems
Russia's Fossil Fuel Revenues Approach €900 Billion Since Ukraine Invasion
U.S. Justice Department Reduces American Bar Association's Role in Judicial Nominations
U.S. Department of Energy Unveils 'Doudna' Supercomputer to Advance AI Research
U.S. SEC Dismisses Lawsuit Against Binance Amid Regulatory Shift
Alcohol Industry Faces Increased Scrutiny Amid Health Concerns
×